Correlation between changes after 24 weeks treatment in body weight and creatinine eGFR ( A ), cystatin-C eGFR ( B ) and iohexol mGFR ( C )
While the drug is a potential game changer for people who are sick from obesity, it is a lifelong commitment, Francesco Rubino, chair of metabolic surgery at King's College London, told Insider
[2] NICE recommends that GLP-1 receptor agonist therapy should be reviewed at 6 months to assess response and determine whether treatment should continue
These patterns underscore that obesity is a chronic condition requiring long-term management rather than short-term treatment
The populations were matched by sex, height, weight, race, ethnicity, social vulnerability index (SVI), and age
Debunking Common Myths About Weight Loss Medications Can You Take Mounjaro or Ozempic After Gastric Sleeve or Gastric Bypass